They know what we have as well!
Going to be a very very interesting year for Paxalisib after the last 6 years it will be terrific to see it progress to an FDA application…
And though any amount of time is too long for investors it’s progressed in remarkably short time.
Ann: Substantial shareholder notice, page-3
-
- There are more pages in this discussion • 6 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)